Pfeifer Protocol
Pfeifer Protocol for Hormone Refractory Prostate Cancer
Source: Pfeifer Protocol
Our protocol for hormone refractory prostate cancer can vary depending upon the individual patient’s situation.
Prostate Cancer Protocol Success
Clinical studies are showing this protocol successful in 65% of the patients that Dr. Pfeifer has used it on, even though it has largely been used with patients that have either failed conventional treatments or have been unable to tolerate them. This phytotherapy treatment program has none of the harsh side effects experienced using standard therapies for this disease. The successful results of his trial have been published in the January 2005 edition of Oncology, a Swiss medical journal (www.tellmed.ch). He now lectures around the world educating cancer specialists about his protocol.
This protocol has been reported to produce 50% reduction of PSA by 6 months in up to 70% of such patients treated in Switzerland with minimal side effects (Pfeifer and Aeikens Positive Health 2006, 120:19-25/ www.positivehealth.com).
Continue reading about this treatment at Pfeifer Protocol
Prostate Cancer, Prof Pfeifer’s Protocol
Source: Holistic Medical Clinic
The protocol has been reported to produce a 50% reduction of PSA by 6 months in 70% of patients treated in Switzerland, with minimum side effects. In a trial of 194 patients with prostate cancer 2/3 had a 50% reduction in PSA values, a decrease in tumour volume, decrease in pain, and an improvement in quality of life. A follow up of 1250 patients over 6 years showed a 60% maintained reduction in PSA.The Pfeifer Protocol is used as a complementary treatment along side existing orthodox medical or surgical treatments. It can also be used instead of “watchful waiting” in low Gleason score prostate cancer cases. The Pfeifer protocol is not a cure for prostate cancer, but a way of decreasing the PSA in 50% of cases and hopefully keeping the cancer in check.
The Protocol consists of four different products:
PROSTASOL a herbal food supplement containing herbs such as saw palmetto, pygeum, reish, ginger, nettle, skullcap, beta sisterol, camposterol, stimgasteraol, brassicasterol,quercetin, and others. Prostasol has an anti inflammatory, antioxidant and apoptotic effects on prostate cancer cells.
BIOBRAN is derived from rice bran and shitake mushrooms. It is a powerful immune stimulator and increases natural killer cells (NK cells) as well as T and B cells. The Biobran increases macrophage activity leading to an increase in TNF alpha and IL 6, this therefore increases the immune system.
CURCUMIN COMPLEX contains the potent anti-inflammatory and antioxidant curcumin found in the spice tumeric, plus resveratrol.
IMUPROS is a blend of nutritional supplements with vitamins, trace elements, ginseng, lycopene and green tea extract together with selenium, vitamin C, D and E.
PROSTASOL, BIOBRAN, CURCUMIN COMPLEX, and IMUPROS are available at The Really Healthy Company
Dr Pfeifer
Dr Pfeifer is an integrative oncologist with more than 35 years’ experience using both conventional and complementary therapies. He is Director for Research & Development at Aeskulap-International in Switzerland and has a book published, 76 publications in peer reviewed medical journals and 56 presented papers at national and international medical conferences.
Getting started
First a warning to anyone buying online – do check that you are getting a quality product. Dr Pfeifer warned that fake versions of these products have been found selling online.
And a warning again to get support from a doctor who can organise the necessary PSA tests and make judgements about how this fits with other treatment you may be having. Source: YesToLife
It is important to note that Ben Pfeifer’s protocol is for hormone refractory prostate cancer and the results vary, depending upon the case. The protocol has been less successful when not tailored to the PSA level and/or when patients stop taking their normal conventional medication – Canceractive.com
This study looked at the effects of ProstaSol™
A total of 96 patients with advanced metastatic prostate cancer (stage D3) were enrolled into a prospective clinical trial to evaluate possible toxic and beneficial effects of ProstaSol™. After failing hormone-ablative therapy and with established disease progression, all patients received supplemental treatment with ProstaSol™ (2880mg daily for the first month, 1800 mg per day for the second month, 1200 mg per day in the third months, and between 900 to 1200 mg from the fourth month on) for a total follow-up of nine months. Hormonal therapy was continued throughout the trial to avoid the known withdrawal effect of anti-androgen on PSA.
Results: Supplemental ProstaSol™ intake was associated with significant improvements in quality of life measures, reductions in patients’ pain ratings, and a decline in PSA levels without major side effects.
Page last updated January 2026